PL71145B1 - Oxazole derivatives[ie32086l] - Google Patents

Oxazole derivatives[ie32086l] Download PDF

Info

Publication number
PL71145B1
PL71145B1 PL12630768A PL12630768A PL71145B1 PL 71145 B1 PL71145 B1 PL 71145B1 PL 12630768 A PL12630768 A PL 12630768A PL 12630768 A PL12630768 A PL 12630768A PL 71145 B1 PL71145 B1 PL 71145B1
Authority
PL
Poland
Prior art keywords
group
oxazole
formula
general formula
acid
Prior art date
Application number
PL12630768A
Other languages
English (en)
Polish (pl)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of PL71145B1 publication Critical patent/PL71145B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL12630768A 1967-06-14 1968-04-08 Oxazole derivatives[ie32086l] PL71145B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2738267 1967-06-14
GB3759867 1967-08-16

Publications (1)

Publication Number Publication Date
PL71145B1 true PL71145B1 (en) 1974-04-30

Family

ID=26258780

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12630768A PL71145B1 (en) 1967-06-14 1968-04-08 Oxazole derivatives[ie32086l]

Country Status (15)

Country Link
JP (1) JPS4938268B1 (ja)
BE (1) BE713392A (ja)
CH (1) CH560204A5 (ja)
DE (1) DE1770177A1 (ja)
DK (1) DK137674B (ja)
ES (1) ES352579A1 (ja)
FR (2) FR1587052A (ja)
GB (1) GB1226548A (ja)
IE (1) IE32086B1 (ja)
IL (1) IL29654A (ja)
IT (1) IT1053686B (ja)
LU (1) LU55869A1 (ja)
NL (1) NL6805103A (ja)
PL (1) PL71145B1 (ja)
SE (1) SE374745B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794096A (fr) * 1972-08-07 1973-05-16 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
JPS58183676A (ja) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd オキサゾ−ル誘導体
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Also Published As

Publication number Publication date
IT1053686B (it) 1981-10-10
FR8056M (ja) 1970-07-06
GB1226548A (ja) 1971-03-31
DE1770177A1 (de) 1972-03-16
DK137674B (da) 1978-04-17
IL29654A (en) 1974-05-16
LU55869A1 (ja) 1968-07-09
BE713392A (ja) 1968-10-08
FR1587052A (ja) 1970-03-13
DK137674C (ja) 1978-09-25
IE32086L (en) 1968-12-14
SE374745B (ja) 1975-03-17
NL6805103A (ja) 1968-12-16
JPS4938268B1 (ja) 1974-10-16
ES352579A1 (es) 1970-01-01
IE32086B1 (en) 1973-04-04
CH560204A5 (ja) 1975-03-27

Similar Documents

Publication Publication Date Title
EP0004279B1 (de) Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel
DE69232003T2 (de) Benzanilidderivate als 5-HT1D-Antagonisten
HU198030B (en) Process for production of derivatives of benzotiasole and benzotiophen and medical preparatives containing these compounds as active substance
DE19943634A1 (de) Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
US4006180A (en) [1,3-Dihydroxy-2-substituted and 2,2-disubstituted-indanyloxy(or thio)]alkanoic acids
DD201790A5 (de) Verfahren zur herstellung von 3-aryl-5-isothiazolen
EP0150166B1 (en) Novel arylacitic acid derivatives
US3956374A (en) Aryl-oxo-heptenoic acids
US4401669A (en) 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension
PL71145B1 (en) Oxazole derivatives[ie32086l]
EP0068386B1 (de) Substituierte Imidazo(1,5-a)pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten
DE2737407A1 (de) Verfahren zur herstellung neuer benzopyranderivate
DE2536003A1 (de) Neue pyrazol-derivate, ihre herstellung und verwendung
AU695925B2 (en) Novel benzothiazole derivatives
US3997589A (en) 4-(2'-Fluoro-4-biphenylylr-4-oxo-butyric acid and esters and salts thereof
US3453285A (en) Tetrazolyl alkanoic acids
US4219657A (en) Dibenzothiophenes
DE2812353A1 (de) Oxazol- und thiazol-alkansaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
GB1562943A (en) Pyrazole derivatives and their manufacture and use
DE3872576T2 (de) Leukotrienantagonisten.
US3743646A (en) Amides of 3-(2-halophenyl-5-tetrazolyl)propionic acids
HU178851B (en) Process for preparing new benzthiazol derivatives
US3781295A (en) Pyridyl ketipate lactones and derivatives
US3597429A (en) Derivatives of tetrazolyl alkanoic acids